Cargando…
Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study
OBJECTIVES: A number of observational studies have reported that, in patients with chronic obstructive pulmonary disease (COPD), β blockers (BBs) decrease risk of mortality and COPD exacerbations. To address important methodological concerns of these studies, we compared the effectiveness and safety...
Autores principales: | Dong, Yaa-Hui, Alcusky, Matthew, Maio, Vittorio, Liu, Jun, Liu, Mengdan, Wu, Li-Chiu, Chang, Chia-Hsuin, Lai, Mei-Shu, Gagne, Joshua J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387948/ https://www.ncbi.nlm.nih.gov/pubmed/28363921 http://dx.doi.org/10.1136/bmjopen-2016-012997 |
Ejemplares similares
-
An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015) -
Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD)
por: Grimaldi-Bensouda, Lamiae, et al.
Publicado: (2016) -
Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023) -
Pleiotropic Effects of Calcium Channel Blockers
por: Preston Mason, R.
Publicado: (2012) -
Calcium channel blockers and Alzheimer's disease★
por: Tan, Yi, et al.
Publicado: (2012)